BRCA1 Reflects Myocardial Adverse Remodeling in Idiopathic Dilated Cardiomyopathy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Transplantation Proceedings

• Publication date

  2016-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.transproceed.2015.12.141PMID 27496484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.

  2014cited by this paper
• BRCA1 deficiency induces protective autophagy to mitigate stress and provides a mechanism for BRCA1 haploinsufficiency in tumorigenesis.

  2014cited by this paper
• Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

  2014cited by this paper
• FoCUS: 50 YEARS oF DNA REPAiR: THE YALE SYMPoSiUM REPoRTS

  2013cited by this paper
• BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.

  2013cited by this paper
• A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screening

  2013cited by this paper
• BRCA1 is an essential regulator of heart function and survival following myocardial infarction

  2011cited by this paper
• Cardiomyocyte hypertrophy, oncosis, and autophagic vacuolization predict mortality in idiopathic dilated cardiomyopathy with advanced heart failure.

  2011cited by this paper
• BRCA1 negatively regulates formation of autophagic vacuoles in MCF-7 breast cancer cells.

  2010cited by this paper
• Ca2+/Calmodulin-Dependent Kinase II&dgr; Causes Heart Failure by Accumulation of p53 in Dilated Cardiomyopathy

  2010cited by this paper
• Mechanisms of non-apoptotic programmed cell death in diabetes and heart failure

  2010cited by this paper
• BRCA1, Hormone, and Tissue-Specific Tumor Suppression

  2008cited by this paper
• The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications

  2005cited by this paper
• Myocytes Die by Multiple Mechanisms in Failing Human Hearts

  2003cited by this paper
• Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.

  2001cited by this paper
• Association between the severity of heart failure and the susceptibility of myocytes to apoptosis in patients with idiopathic dilated cardiomyopathy.

  2001cited by this paper
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000cited by this paper
• Apoptosis in the failing human heart.

  1997cited by this paper
• Apoptosis in myocytes in end-stage heart failure.

  1996cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper

• Breast cancer susceptibility gene 2 upregulation alleviated cardiac hypertrophy in angiotensin II-treated mice

  2026cites this paper
• DNA Damage and repair in Cardiomyopathy: Mechanisms and Therapeutic Opportunities.

  2025cites this paper
• Left ventricular global longitudinal strain is worse in BRCA mutation positive breast cancer patients prior to cancer treatment and premature menopause

  2024cites this paper
• Endothelial Cell-specific Loss of Breast Cancer Susceptibility Gene 2 Exacerbates Atherosclerosis

  2023cites this paper
• Effects of Breast Cancer Genes 1 and 2 on Cardiovascular Diseases.

  2019cites this paper
• An Exploratory Study to Determine Whether BRCA1 and BRCA2 Mutation Carriers Have Higher Risk of Cardiac Toxicity

  2017cites this paper